ILMN vs PATH
Illumina Inc (ILMN) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Illumina Inc (ILMN) is a diagnostics & research company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported ILMN revenue for 2025-12-28 was $4.34B. Net income was $850.0M. Revenue was down 0.7% from 2024-12-29 to 2025-12-28. ILMN currently screens at market cap $15.84B.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
ILMN currently screens at market cap $15.84B. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the ILMN and PATH stock pages for the full models.
Not investment advice.